GlassScriptPhysician profile
Jamie Kim
NPI 1275870842
$2,167.53
in general payments reported to CMS, 2019-2025
10 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $261 · 2021: $85.21 · 2022: $359 · 2023: $338 · 2024: $286 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $818.88 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Smith+Nephew, INC. | $583.11 | 2019-2024 | Collagenase Santyl |
| Integra Lifesciences Corporation | $286.46 | 2022-2025 | Tcc-Ez, Integra, Primatrix |
| Paragon 28, INC. | $236.56 | 2022-2025 | Phantom Fibula Nail, Trauma |
| Evolution Surgical, INC | $82.71 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $63.75 | 2024 | Myfembree |
| Organogenesis INC. | $43.70 | 2023 | Puraply |
| Acera Surgical, INC. | $19.41 | 2025 | Restrata Wound Matrix |
| Osiris Therapeutics INC. | $18.80 | 2019 | |
| Bioventus LLC | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.